EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE, covering 2020-05-14 to 2020-05-14. Get the full timeline:
Most recent: FDA Approved: EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)